179 related articles for article (PubMed ID: 16996663)
21. Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi.
Xu Q; McShan K; Liang FT
Mol Microbiol; 2007 Apr; 64(1):220-31. PubMed ID: 17376084
[TBL] [Abstract][Full Text] [Related]
22. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
Beran J; De Clercq N; Dieussaert I; Van Hoecke C
Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
[TBL] [Abstract][Full Text] [Related]
23. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.
Rudolph MJ; Davis SA; Haque HME; Weis DD; Vance DJ; Piazza CL; Ejemel M; Cavacini L; Wang Y; Mbow ML; Gilmore RD; Mantis NJ
mBio; 2023 Apr; 14(2):e0298122. PubMed ID: 36976016
[TBL] [Abstract][Full Text] [Related]
24. Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
Kolb P; Wallich R; Nassal M
PLoS One; 2015; 10(9):e0136180. PubMed ID: 26352137
[TBL] [Abstract][Full Text] [Related]
25. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses.
Scheiblhofer S; Weiss R; Dürnberger H; Mostböck S; Breitenbach M; Livey I; Thalhamer J
Microbes Infect; 2003 Sep; 5(11):939-46. PubMed ID: 12941385
[TBL] [Abstract][Full Text] [Related]
26. Chemoenzymatic synthesis of a glycolipid library and elucidation of the antigenic epitope for construction of a vaccine against Lyme disease.
Stübs G; Rupp B; Schumann RR; Schröder NW; Rademann J
Chemistry; 2010 Mar; 16(11):3536-44. PubMed ID: 20143357
[TBL] [Abstract][Full Text] [Related]
27. Multicomponent Lyme vaccine: three is not a crowd.
Brown EL; Kim JH; Reisenbichler ES; Höök M
Vaccine; 2005 May; 23(28):3687-96. PubMed ID: 15882529
[TBL] [Abstract][Full Text] [Related]
28. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
29. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
[TBL] [Abstract][Full Text] [Related]
30. Progress and controversy surrounding vaccines against Lyme disease.
Hanson MS; Edelman R
Expert Rev Vaccines; 2003 Oct; 2(5):683-703. PubMed ID: 14711329
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.
Křupka M; Mašek J; Bartheldyová E; Turánek Knötigová P; Plocková J; Korvasová Z; Škrabalová M; Koudelka Š; Kulich P; Zachová K; Czerneková L; Strouhal O; Horynová M; Šebela M; Miller AD; Ledvina M; Raška M; Turánek J
J Control Release; 2012 Jun; 160(2):374-81. PubMed ID: 22387453
[TBL] [Abstract][Full Text] [Related]
32. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
[TBL] [Abstract][Full Text] [Related]
33. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis.
Liang FT; Jacobs MB; Bowers LC; Philipp MT
J Exp Med; 2002 Feb; 195(4):415-22. PubMed ID: 11854355
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
Ledue TB; Collins MF; Young J; Schriefer ME
Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
[TBL] [Abstract][Full Text] [Related]
35. Eliminating Factor H-Binding Activity of
Marcinkiewicz AL; Lieknina I; Kotelovica S; Yang X; Kraiczy P; Pal U; Lin YP; Tars K
Front Immunol; 2018; 9():181. PubMed ID: 29472926
[TBL] [Abstract][Full Text] [Related]
36. Borrelia burgdorferi complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to nondenatured structural determinants.
Rossmann E; Kitiratschky V; Hofmann H; Kraiczy P; Simon MM; Wallich R
Infect Immun; 2006 Dec; 74(12):7024-8. PubMed ID: 17000728
[TBL] [Abstract][Full Text] [Related]
37. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
Baum E; Randall AZ; Zeller M; Barbour AG
PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
[TBL] [Abstract][Full Text] [Related]
38. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi.
Levy S; O'Connor TP; Hanscom JL; Shields P
Vet Ther; 2002; 3(3):308-15. PubMed ID: 12447839
[TBL] [Abstract][Full Text] [Related]
39. The Lyme disease vaccine--a public health perspective.
Shen AK; Mead PS; Beard CB
Clin Infect Dis; 2011 Feb; 52 Suppl 3():s247-52. PubMed ID: 21217171
[TBL] [Abstract][Full Text] [Related]
40. Asymptomatic infection with Borrelia burgdorferi.
Steere AC; Sikand VK; Schoen RT; Nowakowski J
Clin Infect Dis; 2003 Aug; 37(4):528-32. PubMed ID: 12905137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
